Any bleeding episode whether treated or untreated.
Activated prothrombin complex concentrate (aPCC) is a scientific term for the bypassing therapy Feiba®.
A type of treatment developed for people with inhibitors; bypassing treatments go around (or bypass) the factors that are blocked by the inhibitor to help the body form a normal clot.
A treatment that replaces the low or missing factor in people with hemophilia so that blood will clot if you have an injury.
A method to deliver medicine into the body that involves inserting a needle directly into the vein.
The movement of a drug into, through, and out of the body.
The regular use of a medicine to prevent something from occurring. In hemophilia, prophylaxis is intended to prevent or reduce bleeding.
A method to deliver medicine into the body that involves inserting a needle into the fatty tissue just beneath the skin.
Therapeutic antibodies, often referred to as monoclonal antibodies, are designed to have the same ability as natural antibodies to bind to specific molecules. They are laboratory-produced molecules that are designed to recognize and attach to specific proteins to help treat a disease.
A bleed that requires treatment as determined by the individual or their healthcare provider.
Link to Healthcare Professionals Site
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Link to Third-Party Site
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.